CLINICAL_TRIALS
trial_result
· 2019-12-02
Clinical Trial Update: A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia [Phase 2]
Summary
A Phase 2 clinical trial evaluating safety and efficacy of SHR4640 in combination with febuxostat for hyperuricemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Hyperuricemia | Phase 2 | Status: UNKNOWN